The findings in the study reveal that these engineered exosomes proficiently delivered BDNF to neurons, alleviating depression-like behavior induced by LPS and reducing neuroinflammation by modulating the BDNF-TrkB signaling pathway. The gene discussed is NTRK2; the disease is depressive symptom measurement.